Close
Novotech
Jabsco PureFlo 21 Single Use

Merck To Present Innovative Products for Displays at the FPD International in Makuhari (Japan)

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

DeepCyte Raises $1.5M funding to Advance AI Drug Toxicology

DeepCyte, a techbio company focused on advancing AI Drug...

Hypercon Technology Deal Signed between Halozyme and Vertex

Halozyme Therapeutics has entered into a global exclusive partnership...

Gilead Advances ADC Pipeline Expansion with $3B Tubulis Deal

Gilead Sciences has agreed to acquire Germany-based Tubulis in...
- Advertisement -

Merck KGaA announced today that it will be exhibiting at the FPD International, one of the leading events for the flat panel display industry, from November 10 to 12, 2010 in Makuhari / Chiba, (Japan). The global pharmaceutical and chemical company will be highlighting its innovative products for the display, lighting and photovoltaics segments.

Within its liquid crystal product range, Merck is going to present PS-VA (PS-VA = Polymer-Stabilized-Vertical-Alignment), a novel premium technology that offers better contrast, greater brightness, faster switching speed and makes it possible to reduce power consumption in LCD televisions. The colors appear more intense, warmer, and more natural. In addition, the spatial depth of the display is greater and movements are more lively. Also the newest screen-generation – 3D displays – will profit from this Merck technology. Merck’s PS-VA materials are a part of the innovative licristal® portfolio, which is based on a combination of a liquid crystals mixture with specially designed reactive mesogens resulting from a sophisticated production process.

Merck will also be providing information on its liquid crystal materials for ultra-fast switchable Blue Phase devices, which is seen as a future technology for extremely rapid picture motion, high contrast ratio and wide viewing angle. Cost-effective production is predicted due to the cell layout without alignment layers and less critical cell gap control.

 

 

Latest stories

Related stories

DeepCyte Raises $1.5M funding to Advance AI Drug Toxicology

DeepCyte, a techbio company focused on advancing AI Drug...

Hypercon Technology Deal Signed between Halozyme and Vertex

Halozyme Therapeutics has entered into a global exclusive partnership...

Gilead Advances ADC Pipeline Expansion with $3B Tubulis Deal

Gilead Sciences has agreed to acquire Germany-based Tubulis in...

Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition

Neurocrine Biosciences is close to securing a more than...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »